Literature DB >> 17380342

[Diagnostic strategies for autoimmune rheumatic diseases].

A S Wiik1.   

Abstract

In order to help the clinical rheumatologist set an early and precise diagnosis and plan a rational follow-up, a close collaboration between all parties involved in the diagnostic work-up must be established. Autoimmune serology plays a key role in achieving this goal by choosing test methods that are ideal from a clinical standpoint and by presenting results obtained in such a fashion that even less experienced clinicians can correctly use the information. Simple algorithms for test ordering and for the interpretation of laboratory findings are of great benefit in daily practice, but such tools must be mutually agreed upon by the laboratory and clinical scientists. A precise diagnosis and estimation of prognosis is instrumental for optimal decision making in the clinic, but this is too complicated to be left to chance due to the inappropriate use of information. Late or wrong decisions during follow-up lead to unnecessary suffering and far higher lifetime costs for chronic diseases such as those found in rheumatology.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17380342     DOI: 10.1007/s00393-007-0160-x

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  10 in total

Review 1.  Clinical use of serological tests for antineutrophil cytoplasmic antibodies. What do the studies say?

Authors:  A S Wiik
Journal:  Rheum Dis Clin North Am       Date:  2001-11       Impact factor: 2.670

Review 2.  Appropriateness in anti-nuclear antibody testing: from clinical request to strategic laboratory practice.

Authors:  N Bizzaro; A Wiik
Journal:  Clin Exp Rheumatol       Date:  2004 May-Jun       Impact factor: 4.473

Review 3.  Cutting edge diagnostics in rheumatology: the role of patients, clinicians, and laboratory scientists in optimizing the use of autoimmune serology.

Authors:  Allan S Wiik; Thomas P Gordon; Arthur F Kavanaugh; Robert G Lahita; Westley Reeves; Walther J van Venrooij; Merlin R Wilson; Marvin Fritzler
Journal:  Arthritis Rheum       Date:  2004-04-15

Review 4.  Anti-nuclear autoantibodies: clinical utility for diagnosis, prognosis, monitoring, and planning of treatment strategy in systemic immunoinflammatory diseases.

Authors:  A S Wiik
Journal:  Scand J Rheumatol       Date:  2005 Jul-Aug       Impact factor: 3.641

5.  European attempts to set guidelines for improving diagnostics of autoimmune rheumatic disorders.

Authors:  A Wiik; R Cervera; M Haass; C Kallenberg; M Khamashta; P L Meroni; J-C Piette; R Schmitt; Y Shoenfeld
Journal:  Lupus       Date:  2006       Impact factor: 2.911

6.  Anti-DNA antibodies: a diagnostic and prognostic tool for systemic lupus erythematosus?

Authors:  Piersandro Riboldi; Maria Gerosa; Gabriella Moroni; Antonella Radice; Flavio Allegri; Alberto Sinico; Angela Tincani; Pier Luigi Meroni
Journal:  Autoimmunity       Date:  2005-02       Impact factor: 2.815

7.  Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study.

Authors:  E J ter Borg; G Horst; E J Hummel; P C Limburg; C G Kallenberg
Journal:  Arthritis Rheum       Date:  1990-05

Review 8.  Laboratory testing in the diagnosis and management of idiopathic inflammatory myopathies.

Authors:  Ira N Targoff
Journal:  Rheum Dis Clin North Am       Date:  2002-11       Impact factor: 2.670

9.  Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides.

Authors:  Branka Bonaci-Nikolic; Milos M Nikolic; Sladjana Andrejevic; Svetlana Zoric; Mirjana Bukilica
Journal:  Arthritis Res Ther       Date:  2005-07-13       Impact factor: 5.156

Review 10.  The use and abuse of commercial kits used to detect autoantibodies.

Authors:  Marvin J Fritzler; Allan Wiik; Mark L Fritzler; Susan G Barr
Journal:  Arthritis Res Ther       Date:  2003-06-09       Impact factor: 5.156

  10 in total
  2 in total

1.  [New biomarkers for large vessel vasculitis and spondyloarthropathies].

Authors:  N T Baerlecken
Journal:  Z Rheumatol       Date:  2017-08       Impact factor: 1.372

Review 2.  [Laboratory diagnostics for early detection of rheumatic autoimmune diseases: a guide for the general practitioner].

Authors:  Georg Endler; Ulrike Demel; Ernst Forster; Andrea Griesmacher; Christin Hübner; Werner Klotz; Günter Steiner; W Wagner; Manfred Herold
Journal:  Wien Med Wochenschr       Date:  2012-08-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.